Cargando…
Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
An original immuno-regulatory strategy against inflammatory bowel diseases based on the use of 28 kDa glutathione S-transferase (P28GST), a unique schistosome protein, was recently proposed. Improvement of intestinal inflammation occurs through restoration of the immunological balance between pro-in...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627314/ https://www.ncbi.nlm.nih.gov/pubmed/31212833 http://dx.doi.org/10.3390/cells8060577 |
_version_ | 1783434709021229056 |
---|---|
author | Foligné, Benoît Plé, Coline Titécat, Marie Dendooven, Arnaud Pagny, Aurélien Daniel, Catherine Singer, Elisabeth Pottier, Muriel Bertin, Benjamin Neut, Christel Deplanque, Dominique Dubuquoy, Laurent Desreumaux, Pierre Capron, Monique Standaert, Annie |
author_facet | Foligné, Benoît Plé, Coline Titécat, Marie Dendooven, Arnaud Pagny, Aurélien Daniel, Catherine Singer, Elisabeth Pottier, Muriel Bertin, Benjamin Neut, Christel Deplanque, Dominique Dubuquoy, Laurent Desreumaux, Pierre Capron, Monique Standaert, Annie |
author_sort | Foligné, Benoît |
collection | PubMed |
description | An original immuno-regulatory strategy against inflammatory bowel diseases based on the use of 28 kDa glutathione S-transferase (P28GST), a unique schistosome protein, was recently proposed. Improvement of intestinal inflammation occurs through restoration of the immunological balance between pro-inflammatory T-helper 1 (Th1) responses and both T-helper 2 (Th2) and regulatory responses. However, detailed mechanisms explaining how P28GST prevents colitis and promotes gut homeostasis remain unknown. Considering the complex interplay between the adaptive and innate immune system and the intestinal microbiota, we raised the question of the possible role of the microbial ecosystem in the anti-inflammatory effects mediated by the helminth-derived P28GST protein. We first analyzed, by 16S rRNA sequencing, the bacterial profiles of mice fecal microbiota at several time points of the P28GST-immunomodulation period prior to trinitrobenzene sulfonic acid (TNBS)-colitis. The influence of gut microbiota in the P28GST-mediated anti-inflammatory effects was then assessed by fecal microbiota transplantation experiments from P28GST-immunized mice to either conventional or microbiota depleted naïve recipient mice. Finally, the experimental data were supplemented by the temporal fecal microbiota compositions of P28GST-treated Crohn’s disease patients from a pilot clinical study (NCT02281916). The P28GST administration slightly modulated the diversity and composition of mouse fecal microbiota while it significantly reduced experimental colitis in mice. Fecal microbiota transplantation experiments failed to restore the P28GST-induced anti-inflammatory effects. In Crohn’s disease patients, P28GST also induced slight changes in their overall fecal bacterial composition. Collectively, these results provide key elements in both the anti-inflammatory mechanisms and the safe therapeutic use of immunomodulation with such promising helminth-derived molecules. |
format | Online Article Text |
id | pubmed-6627314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66273142019-07-23 Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights Foligné, Benoît Plé, Coline Titécat, Marie Dendooven, Arnaud Pagny, Aurélien Daniel, Catherine Singer, Elisabeth Pottier, Muriel Bertin, Benjamin Neut, Christel Deplanque, Dominique Dubuquoy, Laurent Desreumaux, Pierre Capron, Monique Standaert, Annie Cells Article An original immuno-regulatory strategy against inflammatory bowel diseases based on the use of 28 kDa glutathione S-transferase (P28GST), a unique schistosome protein, was recently proposed. Improvement of intestinal inflammation occurs through restoration of the immunological balance between pro-inflammatory T-helper 1 (Th1) responses and both T-helper 2 (Th2) and regulatory responses. However, detailed mechanisms explaining how P28GST prevents colitis and promotes gut homeostasis remain unknown. Considering the complex interplay between the adaptive and innate immune system and the intestinal microbiota, we raised the question of the possible role of the microbial ecosystem in the anti-inflammatory effects mediated by the helminth-derived P28GST protein. We first analyzed, by 16S rRNA sequencing, the bacterial profiles of mice fecal microbiota at several time points of the P28GST-immunomodulation period prior to trinitrobenzene sulfonic acid (TNBS)-colitis. The influence of gut microbiota in the P28GST-mediated anti-inflammatory effects was then assessed by fecal microbiota transplantation experiments from P28GST-immunized mice to either conventional or microbiota depleted naïve recipient mice. Finally, the experimental data were supplemented by the temporal fecal microbiota compositions of P28GST-treated Crohn’s disease patients from a pilot clinical study (NCT02281916). The P28GST administration slightly modulated the diversity and composition of mouse fecal microbiota while it significantly reduced experimental colitis in mice. Fecal microbiota transplantation experiments failed to restore the P28GST-induced anti-inflammatory effects. In Crohn’s disease patients, P28GST also induced slight changes in their overall fecal bacterial composition. Collectively, these results provide key elements in both the anti-inflammatory mechanisms and the safe therapeutic use of immunomodulation with such promising helminth-derived molecules. MDPI 2019-06-12 /pmc/articles/PMC6627314/ /pubmed/31212833 http://dx.doi.org/10.3390/cells8060577 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Foligné, Benoît Plé, Coline Titécat, Marie Dendooven, Arnaud Pagny, Aurélien Daniel, Catherine Singer, Elisabeth Pottier, Muriel Bertin, Benjamin Neut, Christel Deplanque, Dominique Dubuquoy, Laurent Desreumaux, Pierre Capron, Monique Standaert, Annie Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
title | Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
title_full | Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
title_fullStr | Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
title_full_unstemmed | Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
title_short | Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
title_sort | contribution of the gut microbiota in p28gst-mediated anti-inflammatory effects: experimental and clinical insights |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627314/ https://www.ncbi.nlm.nih.gov/pubmed/31212833 http://dx.doi.org/10.3390/cells8060577 |
work_keys_str_mv | AT folignebenoit contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT plecoline contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT titecatmarie contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT dendoovenarnaud contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT pagnyaurelien contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT danielcatherine contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT singerelisabeth contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT pottiermuriel contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT bertinbenjamin contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT neutchristel contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT deplanquedominique contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT dubuquoylaurent contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT desreumauxpierre contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT capronmonique contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights AT standaertannie contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights |